Successful Surgical Treatment of Pediatric FUS::TFCP2-Positive Rhabdomyosarcoma of the Mandible: A Case Report
International Journal of Surgical Pathology
Published online on March 09, 2026
Abstract
International Journal of Surgical Pathology, Volume 34, Issue 5, Page 1247-1255, August 2026.
FUS::TFCP2-positive rhabdomyosarcoma (RMS) is a rare and aggressive subtype that was recently classified as a distinct entity. It is resistant to conventional chemotherapeutic regimens for RMS, and optimal treatment strategies have not been established. ...
FUS::TFCP2-positive rhabdomyosarcoma (RMS) is a rare and aggressive subtype that was recently classified as a distinct entity. It is resistant to conventional chemotherapeutic regimens for RMS, and optimal treatment strategies have not been established. ...